Free Radical Research Communications · 1990 · 50 citations · 20 references
MedicineOncologyPharmacologyBiochemical PharmacologyDrug MetabolismMolecular OncologyCarcinogen MetabolismEnzyme InhibitionBenzene MetabolismBioreductive ActivationBioreductive Drug ActivationBone Marrow - Derived CellsDeactivation MechanismsStromal Cell Activation
Bioactivation of diaziquone (AZQ) in HT-29 human colon carcinoma cells and detoxification of benzene metabolites in bone marrow stromal cells were used as examples of the potential role of DT-diaphorase in both activation and deactivation processes. HT-29 cell cytosol contained high levels of DT-diaphorase activity and removed AZQ in the presence of either NADH or NADPH. Prior boiling of cytosol, omission of NADH or NADPH or inclusion of dicoumarol, an inhibitor of DT-diaphorase, inhibited removal of AZQ. AZQ-induced cytotoxicity in HT-29 cells was also inhibited by dicoumarol. Chemical reduction of AZQ in a cell free system enhanced formation of a GSH conjugate of AZQ. Two of the major cell types in bone marrow stroma are macrophages and fibroblastoid stromal cells. A fibroblastoid cell line derived from stromal cells contained approximately fourfold higher levels of DT-diaphorase than macrophages. Inclusion of dicoumarol in incubations containing 14C-hydroquinone and the respective stromal cell type, significantly increased covalent binding of radiolabel to macromolecules in stromal fibroblasts but not in macrophages.
20
Hjördis Thor, Martyn T. Smith, Pia Hartzell et al. · Journal of Biological Chemistry · 1982 · 903 citations · Full text
Ann M. Benson, Markus J. Hunkeler, Paul Talalay · Proceedings of the National Academy of Sciences · 1980 · 752 citations · Full text
Toxicology of the blood and bone marrow
Food and Chemical Toxicology · 1985 · 109 citations